US Stock MarketDetailed Quotes

ANAB AnaptysBio

Watchlist
  • 13.890
  • -0.080-0.57%
Close Dec 24 13:00 ET
  • 13.890
  • 0.0000.00%
Post 13:01 ET
422.65MMarket Cap-2.30P/E (TTM)

AnaptysBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AnaptysBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.356M--
--2024/Q4-- / 7.786M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.356M--
--2024/Q4-- / 7.786M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--

Unlock Free Earnings Estimates

AnaptysBio Earnings Reports

  • AnaptysBio | 10-Q: Q3 2024 Earnings Report

    Nov 5 16:22 ET

  • AnaptysBio | 8-K: Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

    Nov 5 16:21 ET

  • AnaptysBio | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:27 ET

  • AnaptysBio | 8-K: Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5 16:23 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +1.41%
    Workday
    WDAY
    +1.38%
    Dorian LPG
    LPG
    +1.12%
    DexCom
    DXCM
    +0.88%
    Precision Drilling
    PDS
    +0.86%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 25, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data